RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia

This study has been terminated.

( This study was stopped due to slow enrollment after enrolling 25 of 200 patients. )

Study NCT00495378 Information provided by Ortho Biotech, Inc.

First Received: June 29, 2007 Last Updated: July 2, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	March 2003
Estimated Primary Completion Date:	No date given